Viking Therapeutics Inc. (VKTX)

10.45
NASDAQ : Health Technology
Prev Close 10.54
Day Low/High 10.38 / 10.71
52 Wk Low/High 0.97 / 13.43
Avg Volume 3.71M
Exchange NASDAQ
Shares Outstanding 60.66M
Market Cap 639.34M
EPS -0.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Insiders Bullish On Certain Holdings Of WMCR

Insiders Bullish On Certain Holdings Of WMCR

A look at the weighted underlying holdings of the Invesco Wilshire Micro-Cap ETF (WMCR) shows an impressive 18.1% of holdings on a weighted basis have experienced insider buying within the past six months. START SLIDESHOW:10 ETFs With Stocks That Insiders Are Buying » Viking Therapeutics Inc , which makes up 0.50% of the Invesco Wilshire Micro-Cap ETF (WMCR), has seen 4 directors and officers purchase shares in the past six months, according to the recent Form 4 data.

Viking Therapeutics Announces VK5211 Phase 2 Study Results Selected For Plenary Oral Presentation At ASBMR 2018 Annual Meeting

Viking Therapeutics Announces VK5211 Phase 2 Study Results Selected For Plenary Oral Presentation At ASBMR 2018 Annual Meeting

Presentation to Highlight Data for Novel, Orally Available SARM in Patients Recovering from Hip Fracture Surgery

Overall the Market Is in Good Shape

Overall the Market Is in Good Shape

The action started a little slowly this morning but market players shook off early jitters and are doing a nice job of building on yesterday's momentum.

First Week Of VKTX February 2019 Options Trading

First Week Of VKTX February 2019 Options Trading

Investors in Viking Therapeutics Inc saw new options become available this week, for the February 2019 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 239 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Viking Therapeutics Announces Closing Of Public Offering Of Common Stock

Viking Therapeutics Announces Closing Of Public Offering Of Common Stock

SAN DIEGO, June 12, 2018 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the closing of...

Viking Therapeutics Announces Pricing Of $67.5 Million Public Offering Of Common Stock

Viking Therapeutics Announces Pricing Of $67.5 Million Public Offering Of Common Stock

SAN DIEGO, June 7, 2018 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the pricing of its...

Viking Therapeutics Announces Proposed Public Offering Of Common Stock

Viking Therapeutics Announces Proposed Public Offering Of Common Stock

SAN DIEGO, June 6, 2018 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that it intends to...

Interesting VKTX Put And Call Options For January 2020

Interesting VKTX Put And Call Options For January 2020

Investors in Viking Therapeutics Inc saw new options become available today, for the January 2020 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 590 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

There Is Still a Strong Appetite for Big Moving Speculative Names

There Is Still a Strong Appetite for Big Moving Speculative Names

There isn't any big mystery about what is going on here.

VKTX Crosses Above Average Analyst Target

VKTX Crosses Above Average Analyst Target

In recent trading, shares of Viking Therapeutics Inc have crossed above the average analyst 12-month target price of $9.88, changing hands for $9.99/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

First Week Of VKTX July 20th Options Trading

Investors in Viking Therapeutics Inc saw new options become available this week, for the July 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VKTX options chain for the new July 20th contracts and identified the following call contract of particular interest.

Viking Therapeutics To Report Financial Results For First Quarter 2018 On May 9, 2018

Conference Call Scheduled for Wednesday, May 9 at 4:30 p.m. Eastern Time

Interesting VKTX Put And Call Options For June 15th

Investors in Viking Therapeutics Inc saw new options become available this week, for the June 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VKTX options chain for the new June 15th contracts and identified one put and one call contract of particular interest.

Viking Therapeutics Becomes Oversold (VKTX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week of November 16th Options Trading For Viking Therapeutics (VKTX)

First Week of November 16th Options Trading For Viking Therapeutics (VKTX)

Investors in Viking Therapeutics Inc saw new options begin trading this week, for the November 16th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 238 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Viking Therapeutics To Report Financial Results For Fourth Quarter And Year-End 2017 On March 7, 2018

Viking Therapeutics To Report Financial Results For Fourth Quarter And Year-End 2017 On March 7, 2018

Conference Call Scheduled for Wednesday, March 7 at 4:30 p.m. Eastern Time

Sound Familiar? Dovish Fed Talk Induces Stock Reversal

Sound Familiar? Dovish Fed Talk Induces Stock Reversal

The market's reaction to James Bullard's comments this morning is following an all-too-common pattern.

Choppy Market Action This Morning

Choppy Market Action This Morning

The good news is that there is some stock picking that is working well.

How Unusual This Market Action Is

How Unusual This Market Action Is

Despite this huge move over the last five days the indices still have more work to do to make it back to highs.

Traders Need to Adapt to a New Reality

Traders Need to Adapt to a New Reality

The volatility trade that propped up markets is no longer available.

The Confidence in the Dip Buyers Has Weakened

The Confidence in the Dip Buyers Has Weakened

The bears are likely to be increasingly bold if there's a failed bounce.

This 'Correction' May Turn Out to Be Another Dud

This 'Correction' May Turn Out to Be Another Dud

Once the dip buying starts it becomes self-reinforcing.

The Nature of Markets

The Nature of Markets

The best thing you can do right now is work on shopping lists of potential buys.

Biotech Viking Therapeutics Could Double From Here -- But Not Without Risk

Biotech Viking Therapeutics Could Double From Here -- But Not Without Risk

Interest and volume in the stock picked up in September and continues to build.

7 Stocks Under $10 That Could Make You a Lot of Money

7 Stocks Under $10 That Could Make You a Lot of Money

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

5 Stocks Under $10 Set to Soar Higher

5 Stocks Under $10 Set to Soar Higher

These stocks trading for less than $10 a share are within range of triggering breakout trades.